Genpact (NYSE:G): Valuation Insights After Director Share Purchase and Top Dividend Stock Recognition

Simply Wall St
Genpact (NYSE:G) recently drew attention when Director Nicholas C. Gangestad bought 2,000 shares of the company. When insiders invest their own money, it can signal their confidence in the business’s prospects. In addition, Genpact has been highlighted as a top dividend stock due to its consistent payment history and positive growth outlook. These factors have brought Genpact back into focus for investors interested in both income and potential growth. Insider buying often attracts market interest, especially when combined with a solid dividend track record and a history of revenue and earnings growth. Over the past year, Genpact’s stock has returned 18%, outperforming broader benchmarks, and its momentum has been picking up again after a dip last month. The combination of steady returns in recent years, ongoing share buybacks, and a growing dividend are all central to current discussions around Genpact’s valuation. With these indications of confidence and a stock that has been climbing, the question for many investors is whether Genpact presents a real opportunity at this time, or if its future growth is already reflected in the current share price.

Most Popular Narrative: 14.5% Undervalued

According to community narrative, Genpact's shares are currently seen as undervalued by 14.5% compared to fair value, based on future expected earnings growth and margin expansion.

"Accelerated client adoption of Genpact's Advanced Technology Solutions, particularly in data and AI, is expected to drive higher growth and improved margins. These offerings deliver over twice the revenue per headcount compared to legacy services and are expanding at more than double the company’s overall rate. This points toward robust long-term revenue and margin expansion."

Curious about the strategy fueling Genpact’s potential return? There is a bold transformation story reflected in the growth projections and profit outlook. Want to see which performance metrics this narrative highlights as reasons for a potential re-rating? Explore the full breakdown to get the numbers behind this undervaluation argument.

Result: Fair Value of $53 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Genpact's future growth remains at risk if demand for its advanced solutions slows or if ongoing macroeconomic uncertainty persists, which could potentially impact earnings targets.

Find out about the key risks to this Genpact narrative.

Another View: Discounted Cash Flow Signals Even Deeper Value

While analysts point to an undervalued share price based on future earnings, our DCF model takes a different approach. It suggests Genpact may be trading even further below its fair value. Which method gives investors a clearer picture?

Look into how the SWS DCF model arrives at its fair value.
G Discounted Cash Flow as at Aug 2025
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Genpact for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Genpact Narrative

If you have a different perspective or want to see the story for yourself, it’s easy to dive into the data and build your own viewpoint in just a few minutes. do it your way.

A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Genpact.

Looking for More Smart Investment Opportunities?

Unlock a wider world of potential by seeking out companies that match your unique investing style. If you want to build a stronger, more resilient portfolio, now is the time to act on fresh ideas and emerging trends that others might overlook.

  • Boost your portfolio’s income by targeting companies that consistently pay high yields. Start with the best picks from our roundup of dividend stocks with yields > 3%.
  • Stay ahead of the curve by focusing on real innovation with our latest spotlight on AI penny stocks.
  • Find opportunities in a rapidly growing market and tap into the potential of tomorrow’s leaders by browsing the most exciting quantum computing stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Genpact might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com